Product Information
OXAZEPAM 15 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $1.0264 per EA under NDC 69315091201. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
15 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218261On Market Since
7/9/2025
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 15 MG CAPSULE has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0264 per EA |
|---|---|
| All-time high | $1.0980 (Nov 12, 2025) |
| All-time low | $1.0264 (Jun 17, 2026) |
| 52-week high | $1.0980 |
| 52-week low | $1.0264 |
| Median price | $1.0701 |
| Average price | $1.0702 |
| Largest weekly change | -2.5% (Dec 17, 2025) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXAZEPAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 15 MG CAPSULE, manufactured by Leading Pharma, LLC, is $1.0264 per EA (NDC 69315091201), effective Jun 24, 2026.
How has the price of OXAZEPAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 15 MG CAPSULE has declined 4.6%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 15 MG CAPSULE?
Since Aug 27, 2025, the NADAC for OXAZEPAM 15 MG CAPSULE has ranged from a low of $1.0264 (Jun 17, 2026) to a high of $1.0980 (Nov 12, 2025), with a median of $1.0701 per EA.
Are there cheaper alternatives to OXAZEPAM 15 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXAZEPAM 15 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures OXAZEPAM 15 MG CAPSULE?
OXAZEPAM 15 MG CAPSULE (NDC 69315091201) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification